108 related articles for article (PubMed ID: 29693191)
1. miR‑186 functions as a tumor suppressor in osteosarcoma cells by suppressing the malignant phenotype and aerobic glycolysis.
Xiao Q; Wei Z; Li Y; Zhou X; Chen J; Wang T; Shao G; Zhang M; Zhang Z
Oncol Rep; 2018 Jun; 39(6):2703-2710. PubMed ID: 29693191
[TBL] [Abstract][Full Text] [Related]
2. MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein.
Zhang H; Guo X; Feng X; Wang T; Hu Z; Que X; Tian Q; Zhu T; Guo G; Huang W; Li X
Oncotarget; 2017 Jan; 8(2):2342-2355. PubMed ID: 27911265
[TBL] [Abstract][Full Text] [Related]
3. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.
Du JY; Wang LF; Wang Q; Yu LD
Oncol Rep; 2015 Apr; 33(4):1890-8. PubMed ID: 25672572
[TBL] [Abstract][Full Text] [Related]
4. MiR-205 functions as a tumor suppressor via targeting TGF-α in osteosarcoma.
Yang G; Zhang P; Lv A; Liu Y; Wang G
Exp Mol Pathol; 2016 Feb; 100(1):160-6. PubMed ID: 26708425
[TBL] [Abstract][Full Text] [Related]
5. MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt.
Ru N; Zhang F; Liang J; Du Y; Wu W; Wang F; Liu X
Gene; 2018 Mar; 645():163-169. PubMed ID: 29248580
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.
Bao Y; Chen B; Wu Q; Hu K; Xi X; Zhu W; Zhong X; Chen J
Clin Exp Med; 2017 Feb; 17(1):51-58. PubMed ID: 26515813
[TBL] [Abstract][Full Text] [Related]
7. miR‑185 regulates the growth of osteosarcoma cells via targeting Hexokinase 2.
Liu C; Cai L; Li H
Mol Med Rep; 2019 Sep; 20(3):2774-2782. PubMed ID: 31524259
[TBL] [Abstract][Full Text] [Related]
8. [Impact of PTTG1 downregulation on cell proliferation, cell cycle and cell invasion of osteosarcoma and related molecular mechanisms].
Wu D; Xia Y; Xu H; Zhao B; Liang Q; Lu T; Jia J; Dong Y
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):695-8. PubMed ID: 25567598
[TBL] [Abstract][Full Text] [Related]
9. Pituitary tumor transforming gene 1 promotes proliferation and malignant phenotype in osteosarcoma via NF-κB signaling.
Hu X; Yang F; Mei H
J Orthop Sci; 2024 Jan; 29(1):306-314. PubMed ID: 36414514
[TBL] [Abstract][Full Text] [Related]
10. miR-491-3p suppresses the growth and invasion of osteosarcoma cells by targeting TSPAN1.
Duan J; Liu J; Liu Y; Huang B; Rao L
Mol Med Rep; 2017 Oct; 16(4):5568-5574. PubMed ID: 28849017
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma.
Wang Y; Zhang S; Xu Y; Zhang Y; Guan H; Li X; Li Y; Wang Y
Tumour Biol; 2016 Nov; 37(11):15211-15220. PubMed ID: 27683056
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-139 inhibits the proliferation and migration of osteosarcoma cells via targeting forkhead-box P2.
Zhong C; Liu J; Zhang Y; Luo J; Zheng J
Life Sci; 2017 Dec; 191():68-73. PubMed ID: 28993144
[TBL] [Abstract][Full Text] [Related]
13. miR-451 inhibits cell growth, migration and angiogenesis in human osteosarcoma via down-regulating IL 6R.
Liu SY; Deng SY; He YB; Ni GX
Biochem Biophys Res Commun; 2017 Jan; 482(4):987-993. PubMed ID: 27908732
[TBL] [Abstract][Full Text] [Related]
14. miR‑34c‑3p acts as a tumor suppressor gene in osteosarcoma by targeting MARCKS.
Liu H; Su P; Zhi L; Zhao K
Mol Med Rep; 2017 Mar; 15(3):1204-1210. PubMed ID: 28075441
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑466 inhibits cell proliferation and invasion in osteosarcoma by directly targeting insulin receptor substrate 1.
Sun Y; Zhou J; Shi L; Li J; Chen J
Mol Med Rep; 2019 Apr; 19(4):3345-3352. PubMed ID: 30816452
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-187 Inhibits Growth and Metastasis of Osteosarcoma by Downregulating S100A4.
Xiao Y; Zhao Q; Du B; Chen HY; Zhou DZ
Cancer Invest; 2018 Jan; 36(1):1-9. PubMed ID: 29303365
[TBL] [Abstract][Full Text] [Related]
17. miR-217 targeting Wnt5a in osteosarcoma functions as a potential tumor suppressor.
Wei R; Deng Z; Su J
Biomed Pharmacother; 2015 May; 72():158-64. PubMed ID: 26054690
[TBL] [Abstract][Full Text] [Related]
18. SLC9A2, suppressing by the transcription suppressor ETS1, restrains growth and invasion of osteosarcoma via inhibition of aerobic glycolysis.
Han J; Li S; Cao J; Han H; Lu B; Wen T; Bian W
Environ Toxicol; 2024 Jan; 39(1):238-251. PubMed ID: 37688782
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma.
Ren X; Su C
Mol Med Rep; 2020 Sep; 22(3):2183-2190. PubMed ID: 32705189
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-138 functions as a tumor suppressor in osteosarcoma by targeting differentiated embryonic chondrocyte gene 2.
Jiang B; Mu W; Wang J; Lu J; Jiang S; Li L; Xu H; Tian H
J Exp Clin Cancer Res; 2016 Apr; 35():69. PubMed ID: 27095063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
